Lalitha P. Aiyer, M.D., M.S., M.B.A, F.A.I.H.M, I.F.M.C.P

Executive Medical Advisor

  • Healthcare/Pharmaceutical Professional and Triple Board Certified Physician (American Board of Internal Medicine, Integrative Medicine, and Functional Medicine), with over 20+ years of clinical experience with additional 25 years in the Pharmaceutical industry.

  • Has extensive experience in all phases of drug development , licensing and business development, Pharmacovigilance: drug safety and risk management, with additional lead expertise in clinical studies, regulatory affairs, strategic planning, medical policy and mentoring activities.

  • Senior Director /Global Medical Lead at Pfizer for 10 years in Medical Affairs responsible for all phases of drug development.       

  • Executive Director and Head of Pharmacovigilance at Ardea Biosciences, 2014-2015.

  • Vice President, Clinical Development, Safety, and Global Pharmacovigilance at Evofem Biosciences, 2019-2021.

  • Executive Vice President, Clinical Development and Chief Safety Officer at HuyaBio, 2021-2022.